Clinical Scorecard: The Role of Sex Chromosomes in Cardiovascular Disease
At a Glance
Category
Detail
Condition
Cardiovascular Disease (CVD)
Key Mechanisms
Sex chromosome variations including mosaic loss of Y chromosome (mLoY), X chromosome inactivation escape, and altered gene expression affecting myocardial fibrosis, macrophage infiltration, and transforming growth factor beta signalling
Target Population
Individuals with sex chromosome complements (females with XX, males with XY), with focus on sex-specific cardiovascular risk and disease mechanisms
Care Setting
Cardiovascular clinical and research settings focusing on sex-specific diagnosis, risk stratification, and therapeutic intervention
Key Highlights
Mosaic loss of the Y chromosome (mLoY) is strongly linked to heart failure and other CVD mechanisms.
X chromosome inactivation escape leads to higher expression of certain X-linked genes in females, contributing to sex differences in CVD.
Sex chromosomes influence cardiovascular health beyond hormonal effects, acting through direct genetic and epigenetic mechanisms.
Guideline-Based Recommendations
Diagnosis
Consider sex chromosome complement and mosaic loss of Y chromosome as potential biomarkers in CVD risk assessment.
Recognize sex-specific clinical presentations and risk factor impacts in cardiovascular disease evaluation.
Management
Incorporate understanding of sex chromosome–related mechanisms in personalized therapeutic strategies.
Address sex-specific risk factors such as stronger impact of smoking and diabetes in women.
Monitoring & Follow-up
Monitor for sex-specific disease progression patterns, including differences in symptom presentation and outcomes.
Evaluate emerging biomarkers like mLoY for potential use in risk stratification.
Risks
Acknowledge increased susceptibility to certain CVDs based on sex chromosome variations.
Be aware of sex-biased prevalence of specific cardiovascular conditions (e.g., spontaneous coronary artery dissection in women, Brugada syndrome in men).
Patient & Prescribing Data
Patients with cardiovascular disease exhibiting sex-specific risk profiles and genetic backgrounds
Sex chromosome influences may affect disease susceptibility and response to treatment, highlighting the need for sex-informed therapeutic approaches
Clinical Best Practices
Incorporate sex chromosome analysis in cardiovascular research and clinical risk assessment.
Recognize and address sex differences in CVD presentation, risk factors, and outcomes.
Promote further research into sex chromosome mechanisms to improve understanding and management of CVD.
